Medovex Corporation Announces Definitive Agreement to Acquire the Pulmonary Biomedical Services and Patient Delivery Platform of Regenerative Medicine Solutions, LLC
16. Oktober 2018 08:00 ET
|
Medovex Corp.
ALPHARETTA, Ga., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex”) announced today that it has signed a definitive agreement to acquire the pulmonary biomedical...
Medovex Corporation Names William E. Horne Chief Executive Officer and Chairman of the Board
09. Oktober 2018 08:00 ET
|
Medovex Corp.
Seasoned Healthcare Industry Veteran, Founder and Former Chief Executive Officer of Laser Spine Institute to Lead Company Growth Initiative ATLANTA, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Medovex...
Medovex Corporation Receives ISO 13485:2016 Certification
25. September 2018 08:30 ET
|
Medovex Corp.
ATLANTA, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB:MDVX) ("Medovex" or the "Company"), the developer of the DenerveX® System, a new and novel device designed for enduring relief of...
Medovex Corporation’s DenerveX System Demonstrates Clinical Benefits in Patients Suffering from Low Back Facet Joint Pain
02. Juli 2018 08:00 ET
|
Medovex Corp.
Review of Real World Cases from Five Independent Sites Across Europe Demonstrated Reduction in Pain Scores and General Improvement of Health Metrics up to 6 Months Following Treatment as Evidenced by...
Medovex Corporation Announces Columbia Regulatory Approval and Issuance of Two New US Patent Approvals
05. April 2018 09:46 ET
|
Medovex Corp.
ATLANTA, April 05, 2018 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB:MDVX) ("Medovex" or the "Company"), the developer of the DenerveX® System, a new and novel device designed for enduring relief of...
Medovex Corporation Presents Initial Data on the DenerveX® System During NSpine 2nd Platinum Course in Arosa, Switzerland
13. Februar 2018 10:30 ET
|
Medovex Corp.
ATLANTA, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB:MDVX) ("Medovex" or the "Company"), the developer of the DenerveX® System, a new and novel device designed for enduring relief of...
Medovex Corporation Converts IDE Submission to a Pre-Submission with Food and Drug Administration for its DenerveX System
29. Dezember 2017 16:00 ET
|
Medovex Corp.
ATLANTA, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB:MDVX) ("Medovex" or the "Company"), the developer of the DenerveX® System, a new and novel device designed for enduring relief of...
Medovex Corporation Submits IDE with the Food and Drug Administration for its DenerveX System
27. November 2017 08:00 ET
|
Medovex Corp.
ATLANTA, Nov. 27, 2017 (GLOBE NEWSWIRE) -- Medovex Corporation (NASDAQ:MDVX) ("Medovex" or the "Company"), the developer of the DenerveX® System, a new and novel device designed for enduring relief...
Medovex Corporation Releases Letter to Shareholders
20. November 2017 08:00 ET
|
Medovex Corp.
ATLANTA, Nov. 20, 2017 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB:MDVX) ("Medovex" or the "Company"), the developer of the DenerveX® System, a new and novel device designed for enduring relief of...
Medovex Corporation Initiates Move to List on the OTCQB Market
15. November 2017 08:00 ET
|
Medovex Corp.
ATLANTA, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Medovex Corp. (NASDAQ:MDVX) ("Medovex" or the "Company"), the developer of the DenerveX® System, a new and novel device designed for enduring relief of...